MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial

by Luis Rivera, Pornthep Chanthavanich, Airi Põder, P. V. Suryakiran, Archana Jastorff, Marie Van der Wielen
Published 2019